StrideBio
PrivateLast Round
M&A
Apr 5, 2023
Total Funding Raised
$98.2M
Company Overview
StrideBio operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series B round in March 2021.
StrideBio is a biotechnology company that develops innovative gene therapies aimed at treating rare diseases through advanced AAV vector engineering.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StrideBio Comparables
Compare StrideBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 86% | |
| Capsigen | 84% | |
| rAAVen Therapeutics | 84% |
For institutional investors. Book with your work email.
StrideBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 5, 2023 | ||||
| Series B | Mar 16, 2021 | ||||
| Series A | Jun 13, 2018 | ||||
| Seed | Jun 5, 2017 |
For institutional investors. Book with your work email.
StrideBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series B, Series A |
| UF Innovate | Ventures | Series B |
| Acks | Series A |
| Hatteras Venture Partners | Series B, Seed, Series A |
| Pontifax Credit | Series B |
| Northpond Ventures | Series B |
| Novo Holdings | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2023
$12M raised with Ginkgo Bioworks participating.
- Mar 16, 2021
$82M round led by Novo Holdings and Northpond Ventures.
For institutional investors. Book with your work email.
StrideBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StrideBio's valuation, stock price, and market status.
Is StrideBio a public or private company?
StrideBio is a private company.
What is the current stock price of StrideBio?
StrideBio is a private company, so its shares have no public market price. Caplight tracks StrideBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StrideBio worth (valuation)?
Valuation information for StrideBio is not publicly available.
Can I buy StrideBio stock?
StrideBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StrideBio's last funding round?
StrideBio's most recent funding round was M&A on April 5, 2023.
Who are the main investors in StrideBio?
Key investors in StrideBio include Hatteras Venture Partners, Northpond Ventures, Novo Holdings, Northpond Ventures.
Will StrideBio IPO soon?
No public IPO plans have been announced for StrideBio.
How can I track StrideBio secondary market activity?
Caplight tracks bids, offers, and trades in StrideBio's shares on secondary markets.